FDA Approves At-Home Oral Therapy for MDS

The US Food and Drug Administration (FDA) has approved Inqovi, an oral combinatory formulation of decitabine and cedazuridine, for adult patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) that can be taken at home in tablet form.